search

Pfizer announces licensing deal to make COVID drug pill cheaper in poor countries

This Feb. 5, 2021, file photo shows the Pfizer logo displayed at the company's headquarters in New York.  Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. (AP Photo/Mark Lennihan, File)
This Feb. 5, 2021, file photo shows the Pfizer logo displayed at the company's headquarters in New York. Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. (AP Photo/Mark Lennihan, File)

GENEVA — US pharmaceutical giant Pfizer announces a deal to make its oral antiviral COVID-19 medication available more cheaply in poorer countries, if it passes trials and regulatory approval.

The deal with the global Medicines Patent Pool (MPP) will make the candidate drug available at a lower cost in 95 low- and middle-income countries covering around 53 percent of the world’s population.

comments
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed